ARDX Stock Analysis: Buy, Sell, or Hold?

ARDX - Ardelyx, Inc.

PHARMACEUTICAL PREPARATIONS
$5.27
0.11 (2.13%) ▲
5d: -13.04%
30d: -4.53%
90d: -13.75%
HOLD
MODERATE Confidence
Protect Your ARDX Gains
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 03, 2026 29d
Smart Money Accumulation

None View Scanner →

Strength: 8.6/10

Get Alerted When ARDX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: ARDX shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$14.72
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$9.14
42.4% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ARDX is currently trading at $5.27, which is considered oversold relative to its 30-day fair value range of $5.38 to $6.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.2) compared to its historical average (20.4). Remarkably, the market is currently pricing in an annual earnings decline of 20.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ARDX is in a strong uptrend. Immediate support is located at $4.93, while resistance sits at $6.47.

Market Sentiment: ARDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.30 (+209.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $5.38 - $6.10
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Protect Your Profits

Holding ARDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 209.3% below Wall St target ($16.30)
  • CAUTION: 5-day price weakness (-13.0%) - monitor closely

Trading Range Analysis

30-Day Trading Range $5.38 - $6.10
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $4.94
Resistance Level $6.47
Current Trend Strong Uptrend
Technical data as of Jul 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) 10.23
Wall Street Target $16.30 (+209.3%)
Revenue Growth (YoY) 27.5%
Profit Margin -13.6%
Valuation Discount vs History -20.5% cheaper
PE vs Historical 10.2 vs 20.4 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -20.5% (market-implied from PE analysis)
1-Year Target $4.74 (-10%)
2-Year Target $4.27 (-19%)
3-Year Target $3.84 (-27%)
3-Yr Target (if PE normalizes) (PE: 10→20) $7.66 (+45%)
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.2 to 20.4
Stabilization Target: $10.51 (+99.4%)
PE Expansion Potential: +99.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 04, 2026 8:23 AM ET
Data refreshes hourly during market hours. Next update: 9:23 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab SELL 41666 shares 2026-03-16
David M Mott BUY 333333 shares 2026-02-20
Susan Hohenleitner SELL 2033 shares 2026-02-20

Unlock Insider Activity

See real-time buying/selling by company executives for ARDX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1041 62 BUY
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$84 63 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$106 64 BUY
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 51 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
19 analysts
$276 55 HOLD

Advanced ARDX Option Strategies

Professional options setups generated by AI based on today's ARDX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ARDX

ARDX Technical Chart ARDX Price Prediction ARDX Earnings Date ARDX Investment Advisor ARDX Fair Price Analyzer ARDX Options Advisor ARDX Options Chain ARDX Options Analysis ARDX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals